An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Spineology Inc. (NASDAQ: SPIN) appoints Brian Snider as new CEO, effective November 13, 2023, following John Booth's retirement. Snider brings nearly 20 years of experience in the medical device industry, previously serving as Executive VP of Marketing for Alphatec Spine. The Board of Directors expressed confidence in Snider's ability to lead the company's growth and surgical advancement.
Positive
Brian Snider's extensive experience in the medical device industry, including his role in growing Alphatec Spine's market capitalization from $20M to over $1.2B, indicates strong leadership potential for Spineology's future growth and success.
Negative
None.
Brian Snider Appointed New CEO
SAINT PAUL, Minn.--(BUSINESS WIRE)--
Spineology Inc. (“Spineology” or the “Company”), the leader in ultra-minimally invasive spine surgery, announced today that John Booth will retire from his role as Chief Executive Officer of Spineology, effective November 10, 2023. The Board of Directors has selected Brian Snider as its next Chief Executive Officer, effective November 13, 2023. Mr. Booth will remain with Spineology through 2024, serving in an advisory role to facilitate a smooth transition. Mr. Booth will also resign from the Board of Directors, and the Board has nominated Mr. Snider as a Director.
Snider joins Spineology with nearly twenty years of progressive leadership experience in the medical device industry. Most recently he served as Executive Vice President of Marketing for Alphatec Spine (NASDAQ: ATEC), as a member of the executive leadership team that was responsible for growing the company’s market capitalization from $20M to over $1.2B. During his tenure with ATEC, he had accountability for a variety of disciplines in marketing and product development. Most recently, he was responsible for the Biologics, Cervical, and Thoracolumbar business units. Prior to ATEC, Snider spent nine years at NuVasive, Inc., a leader in innovative products and procedures for minimally disruptive spine surgery. During his tenure at NuVasive, Snider held senior level marketing positions in the Thoracolumbar business segment including the flagship procedure, XLIF®. Mr. Snider received his BBA in Marketing and Information Systems from George Washington University and his MBA from the Fuqua School of Business at Duke University.
"It has been a great privilege to work with a talented and passionate group of employees throughout the Company, who together have advanced the field of ultra-minimally invasive spine surgery significantly over the Company’s history," said John Booth. "I have every confidence that the Company will continue to grow and provide disruptive solutions under Brian’s leadership as the next CEO of Spineology."
Ed Spencer, Chairman of the Board of Spineology, expressed thanks for Booth's leadership. "On behalf of the Board of Directors, our employees, and Spineology’s stockholders, I express my deep gratitude to John for his success in leading the Company, as well as for his service as a Spineology Board member for over 20 years."
"As we prepared for John's retirement, the Board unanimously agreed that Brian Snider was well suited to lead Spineology," continued Spencer. "His years of experience in growing evolutionary companies in the minimally invasive spine market will enable him to immediately contribute to Spineology’s continued success."
"I am thrilled to join the Spineology team,” said Snider. “Spineology is a company with a unique procedural foundation that is backed with strong clinical data. I am confident that we will deliver growth and surgical advancement during this next phase. I would like to thank the Board for the opportunity to serve the Spineology team, the shareholders, and most importantly, our patients.”
About Spineology:
Spineology Inc. leads the way in ultra-minimally invasive spine surgery, revolutionizing how spine surgeons treat and heal back pain. Our proprietary Mesh technology sets us apart from traditional fusion procedures enabling surgeons to optimize outcomes while minimizing tissue disruption and enhancing patient recovery. With a strong commitment to patient-centered care and enabling disruptive technologies, Spineology continues to push the boundaries of what is possible in spine surgery today with the tools of tomorrow.
The ticker symbol for Spineology Inc. is SPIN on the NASDAQ stock exchange.
When will Brian Snider assume the role of CEO at Spineology?
Brian Snider will become the CEO of Spineology effective November 13, 2023.
What is Brian Snider's background?
Brian Snider has nearly twenty years of progressive leadership experience in the medical device industry, most recently serving as Executive Vice President of Marketing for Alphatec Spine.
What is John Booth's role after his retirement?
John Booth will remain with Spineology through 2024, serving in an advisory role to facilitate a smooth transition.
as a medical technology company, we improve lives by providing innovative spine surgery solutions through our relentless pursuit of superior outcomes. we are dedicated to the design, development, launch and the delivery of spinal fusion products. we seek to accomplish this by working with spine surgeons to design and develop products and systems that address the entire spinal fusion procedure in the most effective and efficient way possible. our product designs and platforms provide innovation through a focus on simplifying procedures for the surgeon with the ultimate objective of superior outcomes. alphatec spine is seeking growth through innovation and continually developing technologies that will have a greater positive impact on patient care and outcomes. please visit our website for more information: www.alphatecspine.com